This stock is benefiting from India's growing pediatric healthcare market. Why is this stock is the analyst pick of the week?
perinatal care hospital chain reported good performance in the December 2024 quarter with 18% and 11% year-on-year growth in revenue and PAT respectively. The numbers surpassed Reuters-Refinitiv estimates by 3% and 6% respectively. While revenue growth was supported by increased patient volumes and average revenue per patient (ARPP), a significant jump in other income aided the bottom line.
Operational efficiencies aided EBITDA,which grew by 14% year-on-year while the overall occupancy also improved. However, average revenue per occupied bed (ARPOB) declined amid an increase in average length of stay (ALOS) and new bed additions. The company operates 19 hospitals (and five outpatient clinics) across six cities. It has a bed capacity of 1,935 with over 835 doctors.
It is benefitting from the growing paediatric healthcare market. Also, India’s low spending on childcare products and services, high birth rate compared to China and the United States, increasing maternity age, increased focus on preventive healthcare, and expansion of medical tourism are some of the tailwinds. Rainbow is distinctive from its peers as it offers the highest number of beds in paediatric intensive care units and neonatal intensive care units. It operates on a hub-and-spoke model (the central hospital delivers comprehensive outpatient and inpatient care whereas the satellite facilities provide emergency care) that helps in lowering costs.
The operating model focuses on a multi-disciplinary approach with a unique doctor engagement. The